IP4Plasma: A mobile pilot-scale plasma treatment system
In the IP4Plasma project, atmospheric pressure plasma equipment manufacturers and end-users work to overcome the barriers to commercial application of a unique intellectual property right (IPR) portfolio.
€4.8 m
budget
3
years
9
partners
Key numbers
About the project
In the IP4Plasma project, atmospheric pressure plasma equipment manufacturers and end-users will work with leading experts in research and technology innovation to overcome the barriers to commercial application of a unique intellectual property right (IPR) portfolio. The project aimed to bring together different IPR protected atmospheric pressure plasma assisted chemical vapour deposition technologies by demonstrating their applications in the field of medical products and diagnostics. The goal was to establish a mobile pilot-scale plasma treatment system and overcome barriers to commercial application of a unique IPR portfolio of plasma technology.
Impact of the project:
The project aims to fight the second biggest killer among infectious diseases by producing a highly sensitive and affordable tuberculosis test.
Funding instrument EU Seventh Framework Programme

Spinverse’s role
Spinverse coordinated the project and its FP7 funding proposal.
Spinverse helped develop commercialisation of the technology by defining and analysing its markets, competition, customer needs and the state of IPR in its field.
Supporting the UN Sustainable Development Goals
We share what we learn
Read our latest news on our references
